Abstract-An integrated polydimethysiloxane (PDMS) microfluidic system which is composed of two pneumatic micropumps and one micromixer is developed for high-accuracy detection of insulin. The detection method is based on coupling the highly specific technique of 'double-antibody sandwich immunoassay' with the sensitive chemiluminescence of LuminolHydrogen Peroxide (H 2 O 2 ). The immune reactions and other related processes are carried out in the microfluidic system semi automatically. Sample transportation in the microfluidic system is accomplished by two pneumatic PDMS micropumps. Chemiluminescent measurement is conducted in a separate PDMS micromixer using a double-channel syringe pump to inject reagents. Light emitting from this mixer is detected by a highly sensitive photometer when the chemiluminescent regents flow through the mixer chamber. The results indicate that at an actuation pressure of 10psi, a mixer actuation frequency of 5Hz, and an injecting flow rate of 0.5 ml/min, the detection limit of the microfluidic system for insulin is about 10 -10 M.
INTRODUCTION
Diabetes mellitus (DM) is a group of diverse metabolic disorders caused by deficiency or diminished effectiveness of endogenous insulin [1] . It is the third leading cause of diseaserelated death around the world after cancer and cardiovascular disease. At present, the blood glucose test is the most popular clinical diagnostic tool for diabetes but irregular blood glucose level, unfortunately, is not a good early indicator for diabetes diagnosis. Previous studies have shown that insulin, connecting peptide (C-peptide), and interleukin-6 (IL-6) are better suited as early diagnostic immune indicators for the onset of diabetes [2] . Insulin, a hormone produced by the pancreas for converting glucose to energy, is a common clinical indicator. Its abnormity can be detected as an effective auspice to diagnose diabetes at the early stage, which is a great help to diabetes prevention. The traditional test methods for insulin and other indicators in clinical diagnosis, which include enzyme-linked immunosorbent assay (ELISA), radioimmunoassay (RIA), and various chemiluminesence based techniques, are usually based on microplates and large automatic biochemistry analyzers. These methods, while effective, are predominantly laboratory based and require trained technicians. This makes them unsuitable for field testing which is becoming increasingly important for diabetes screening in the developing countries.
Microfluidics, with such advantages as low reagent consumption, short analysis time, high reliability and sensitivity, and multi-process integration [3, 4] , is a rapidly developing field in biomedical testing [5] . In microfluidic systems, the conventional biochemical processes such as sample pretreatment, sample/reagent transport, mixing, reaction, separation, detection and product collection can be carried out automatically on a single chip [6] . Additionally, microfluidic systems have become the most promising tool for handling costly and difficult-to-obtain samples and reagents [7] . More importantly, the portability characteristic of microfluidic systems that arises from their compact form is a key factor for point of care (POC) applications [6] and offers a practical solution to diabetes screening in the rural environment.
Recently, several advancements in measuring insulin using microfluidic devices coupled with novel detection techniques were demonstrated. A carbon nanotube/dihydropyran (MWCNT/DHP) composite sensor in a microfluidic device has been reported to have a detection limit of 1ȝM [8] . A SlipChip based approach was demonstrated to perform bead-based heterogeneous immunoassays with multiple nanoliter-volume samples. An insulin immunoenzymatic assay showed a detection of limit of about 13pM [9] . Another approach used a microfluidic local surface plasmon resonance (LSPR) chip operated with a simple collinear optical system to interrogate specific insulin and anti-insulin antibody reaction in real-time and demonstrated a detection limit of 100ng/ml insulin [10] . Furthermore, by conjugating with a continuous-flow immunosensor, the detection limit of the SPR method can be improved to 1 ng/ml (ppb) with a response time of less than 5 minutes [11] . However, these methods still require labor-intensive processing, large equipment, and trained expert to provide accurate insulin measurements.
In the present study, an integrated PDMS-based microfluidic system coupled with magnetic bead based sandwich ELISA is developed to measure insulin concentrations. Superparamagnetic beads coated with insulin antibodies are used to capture the target insulin molecules. The integrated microfluidic system which is composed of two pneumatic micropumps and one micromixer automates the immuno-reaction process. A chemiluminescent detector is then used to quantify the concentration of the insulin captured by the immuno-beads in the micromixer. With this approach, the developed microfluidic system achieves a low detection limit and a short reaction time. Fig. 1 shows a schematic illustration of the experimental procedure for insulin detection using heterogeneous chemiluminescent immunoassays, which are typically performed in biomedical laboratories manually. In this procedure, carboxyl-modified magnetic microspheres with a mean diameter of ~5ȝm (Tianjin Baseline ChromTech Research Center, China) are used as the solid-phase supports to covalently conjunct primary insulin antibodies in centrifuge tubes ( Fig. 1(1) ). The immunocompetent antibodies conjugated on the bead surface allow the beads to capture the target insulin (antigen). Taking advantage of the specific interaction between the immune beads and insulin, the target insulin molecules are then recognized and form a half sandwich structure in the micromixer chamber with the micro beads. In the presence of an external magnet, the non-reactive insulin molecules are washed away ( Fig. 1(2) - (3)). Then the insulin antibodies labeled with horseradish peroxidase (HRP) are added to form the complete sandwich complexes ( Fig. 1(4) - (5)). After removing the non-reactive materials, luminol and hydrogen oxide (H 2 O 2 ) with the enhancer p-Iodophenol are injected. Under the condition of alkalescence and catalyzed by the HRP of the sandwich complexes, the injected luminol is rapidly oxidized by the H 2 O 2 and emits light at a wavelength of ~425nm with an intensity proportional to the quantity of the HRP ( Fig. 1(6) ). Since the insulin and its secondary antibody are a one-to-one conjugation, the quantity of HRP connected to the secondary Ab is a direct indication of the quantity of the insulin. The emitted light is quantified by a luminometer. All insulin related bio-reagents are obtained from Shanghai E. Star BioTechnology Co., China.
II. MATERIALS AND METHODS
The immune related processes are carried out semiautomatically in the microfluidic system. Traditionally, the immune magnetic beads and bio-samples are first incubated for 60 min to recognize the target insulin. After incubation, the target insulin adhered onto the magnetic beads is then captured using an external magnet. Then wash buffer (PBST) is added to wash away the non-reactive materials. HRP labeled insulin antibody is then manually added and is allowed to interact with the target insulin for 30 min. The unbound, HRP-labeled insulin antibody is then washed away. Finally, luminol, hydrogen dioxide (H 2 O 2 ) and the enhancer (p-Iodophenol) are added for chemiluminescence detection using a luminometer. 
A. Micropump and Micromixer Design
The PDMS based pneumatic micropump and micromixer have similar structures (Fig. 3) and working principles. Both designs consist two thin PDMS layers. The top layer contains either a microchannel (micropump) or a mixing chamber (micromixer) with either one inlet and one outlet or two yshaped inlets and one outlet. The height of the microchannel is 100μm while the diameter and depth of the mixing chamber are 2mm and 100μm, respectively. The micropump and micromixer are operated based on pneumatic peristaltic principles. Their bottom PDMS layer consists of either three (micropump) or six (micromixer) membrane-enclosed air chambers. In the micropump, the three serially-connected air chambers have different volumes and generate fluid movement in the microchannel through sequential diaphragm deflection [12] . In the micromixer, the six air chambers have identical volumes. Mixing is achieved by pneumatically deflecting the six 100ȝm-thick diaphragms of the air chambers. The chambers are connected in series to each other through serpentine microchannels. A miniature air compressor is used to supply the required compressed air and is controlled by an electro solenoid valve (EMV). Air pressure and the EMV frequency are the most critical control parameters of the micropumps and micromixer. 
B. Microabrication Process Flow
The microfluidic system is fabricated using repeatable molding and bonding of the bio-compatible polymer, Polydimethyl Siloxane (PDMS) and glass [13] . The simplified microfabrication process flow is illustrated in Fig. 4 . First, the negative photoresist SU-8 is spin-coated onto a silicon wafer. Then, photolithography is used to define the pattern of the SU-8 template which serves as the master of the PDMS molding process. The molding process consists of pouring PDMS onto the master and curing the liquid polymer on a hot plate. After the cured PDMS replica is formed and removed from the template, it is bonded to additional PDMS layers and glass cover slides. Oxygen plasma treatment is performed prior to the bonding process to ensure a strong irreversible bond. Microfluidic connecters are used to allow fluid in and out of the microfluidic system. Fig. 5 demonstrates the experimental setup of the insulin detection scheme. The setup consists of a mini air compressor (HARGRAVES, D730A-23-01, USA) which supplies compressed air to the pneumatic micropumps and the mixer, and a control circuit which produces a rectangular wave signal that opens and closes the electromagnetic valves to control the air flow (SMC Inc, S070M-5BG-32, Japan). A pressure sensor (OMEGA, DPG1000B-100G, USA) is utilized to monitor the air pressure. Chemiluminescence signals from the micromixer are detected by a photometer (RFL-1A, Remex Co., China). The micromixer is placed in a black box after injecting luminol and H 2 O 2 by the syringe pump. Only light from the micromixing chamber is collected and detected by the photometer. 
IV. EXPERIMENTAL RESULTES AND DISCUSSIONS

A. Experimental Setup
B. Characterizations of the Pneumatic Micropump and the Micromixer
The micropumps and the micromixer are extensively tested prior to insulin detection to determine their operating parameters. The effects of the applied air pressure and the EMV driving frequency on the resultant flow rate of the micropump are explored by pumping ultra pure water. The results from a typical micropump are shown in Fig. 6 . The general trend of the flow rate under a constant pneumatic pressure is ascending with increasing driving frequency. However, the maximum achievable flow rate is limited by the speed of the filling and emptying of the air chambers. When the EMV frequency is too high, the PDMS diaphragm cannot completely deflect and recover back to its original state. This causes the flow rate to fall after an optimal frequency is reached.
The luminol-hydrogen peroxide chemiluminescence system is adopted to evaluate the micromixer's performance under different working conditions of applied air pressure and EMV driving frequency. The peak chemiluminescent light intensity when the reagents flow through the mixing chamber at a constant flow rate of 25ul/min is used as a measure of the mixing efficiency. Fig. 7 shows the results of different air Fig. 7 demonstrates that at air pressures of 5psi and 10psi, the peak chemiluminescent intensity increases with increasing frequency but starts to fall at 10Hz. At an air pressure of 15psi, the light intensity decreases with increasing frequency. Based on this result, it is determined that the optimal working parameters of the micromixer are 10psi and 5Hz. 
C. Insulin Measurement
The insulin measurement process is divided into two procedures. The immuno reactions and related washing steps are carried out semi-automatically in the integrated microfluidic system as shown in Fig. 5 . The chemiluminesce based measurement of antigen insulin between two lays of antibodies is accomplished in a separate micromixer with the help of a syringe pump for reagent injection. The measurement procedure has already been described in detail in Section II. In the microfluidic system, the biochemical reagents and wash buffers are delivered into the mixing chamber by two micropumps operated at an almost identical pumping rate of about 11ul/min. The mixer is operated at a driving frequency of 5Hz and an applied air pressure of 10psi.
Before transporting the reagents, all macro and micro channels of the microfluidic system are primed with a PBS buffer to prevent air bubbles from interfering with the operation of the micropumps and micromixer. The same PBS is also used to wash away unreacted molecules. At the beginning of the test, the reactants are placed in the Tygon tubings which connect the pump outlets to the mixer inlets. Then the micropumps are turned on to transport them into the working mixing chamber.
The immuno reaction process begins with transporting the conjugated magnetic beads produced from the process described in Fig. 1(1) and the insulin solution into the reaction chamber to form the "half -sandwich" structures ( Fig. 1(2-3) ). Then, these structures are pushed out from the mixer. Using the same method, the "half-sandwich" structure and the HRP labeled insulin antibodies are brought together to form the "sandwich complex" (Fig. 1(4-5) ) for the later chemiluminescent determination. Washing procedures are carried out following each immune reaction with the help of a permanent magnet which is fixed on the outer surface of the mixing chamber.
The micromixer used for the chemiluminesce detection is placed in the dark box of the photometer to reduce noise and improve sensitivity. A double-channel syringe pump with two syringes is adopted here to inject reagents into the mixing chamber via a Y-shaped microchannel. The solution which contains the HRP labeled insulin sandwich complex, the hydrogen oxide (7.5 10 -3 M), and the enhancer p-Iodophenol (3mg/ml) is injected by one syringe while a second syringe is used to pump luminol solution (7.8 10 -3 M). The two solutions are pumped into the mixing chamber simultaneously, and allowed to blend well and react ( Fig. 1(6) ). The concentrations of the chemicals adopted to finish this chemiluminescencent measurement have been optimized in advance. Fig. 8 shows the relationship between the chemiluminescence signal (RLU) and the insulin concentration. The detection limit of insulin is found to be 4×10 -10 mol/L which can meet the present clinical requirements and the CV is about 25.7%. The reaction time of the microfluidic system is about 10 minutes as compared to the traditional method of about 120 minutes.
V. CONCLUSIONS
The current study successfully demonstrated a PDMS microfluidic system for insulin measurement by using heterogeneous chemiluminescent immunoassays in a semi- automated process. The two pneumatic micropumps in the system are operated at a flow rate of about 10ȝl/min while the micromixer is at a frequency of 5Hz. The insulin detection limit of the microfluidic system is 4×10 -10 mol/L which meets the common requirement of current clinical studies of diabetes. The reaction time of the immuno reactions in the microfluidic system is about 10 minutes which is more than ten times faster than that of the traditional methods.
